KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements. (2020)

First Author: Au Y
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.56348

Publication URI: https://www.repository.cam.ac.uk/handle/1810/309252

Type: Journal Article/Review